Because biopsy has a high risk of hemorrhage and the findings of CT and MRI are often
ambiguous, especially at the base of the skull, additional methods for the characterization of …

Imaging of somatostatin receptors (SSTRs) using [111In] diethylenetriaminepentaacetic-acid-
octreotide (DTPAOC) has proven to be helpful in the differentiation of meningiomas …

Background and purpose Meningiomas express the somatostatin receptor (SSTR), which
normal bone and brain lack. PET imaging with SSTR ligands such as 68 Ga-DOTATATE …

Purpose PET imaging with somatostatin receptor ligands, such as 68 Ga-DOTATOC, is a
well-established method for detection and target volume definition of meningiomas prior to …

Purpose The goal of this study was to compare the tumor uptake kinetics and diagnostic
value of three 68Ga-DOTA-labeled somatostatin analogues (68Ga-DOTATOC, 68Ga …

Simple Summary [68Ga] Ga-DOTA-SSTR PET imaging has recently been introduced in the
management of patients with brain tumors, mostly meningiomas and pituitary adenomas or …

Purpose To investigate whether the tumour uptake of radionuclide in peptide receptor
radionuclide therapy (PRRT) of meningioma can be predicted by a PET scan with 68 Ga …

68Ga-DOTATOC and 68Ga-DOTATATE are 2 radiolabeled somatostatin analogs for in vivo
diagnosis of neuroendocrine tumors with PET. The aim of the present work was to measure …

Purpose Since meningiomas show a high expression of somatostatin receptor subtype 2,
PET with 68 Ga-DOTATOC was proposed as an additional imaging modality beside CT and …

Meningiomas are known to express somatostatin receptor 2 (SSTR2). PET using the SSTR2
analog 68Ga-DOTATATE has recently been introduced for imaging of meningiomas …